IRIS
IANNUZZO, GABRIELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.524
NA - Nord America 3.933
EU - Europa 3.702
SA - Sud America 699
AF - Africa 138
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 14.000
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.771
SG - Singapore 2.472
RU - Federazione Russa 1.728
VN - Vietnam 1.069
CN - Cina 1.061
IT - Italia 770
BR - Brasile 540
HK - Hong Kong 364
DE - Germania 348
FR - Francia 231
FI - Finlandia 143
NL - Olanda 129
GB - Regno Unito 100
JP - Giappone 96
IN - India 88
CA - Canada 75
AR - Argentina 63
BD - Bangladesh 58
KR - Corea 58
MX - Messico 56
IE - Irlanda 45
CI - Costa d'Avorio 44
TH - Thailandia 44
PL - Polonia 37
PH - Filippine 36
ZA - Sudafrica 35
UA - Ucraina 33
AT - Austria 29
SE - Svezia 29
EC - Ecuador 26
ID - Indonesia 26
IQ - Iraq 26
ES - Italia 20
VE - Venezuela 19
TR - Turchia 18
PK - Pakistan 15
CL - Cile 13
CO - Colombia 12
TW - Taiwan 12
CH - Svizzera 11
MA - Marocco 11
PY - Paraguay 10
KE - Kenya 9
NP - Nepal 9
SA - Arabia Saudita 9
JO - Giordania 8
LT - Lituania 8
DZ - Algeria 7
EG - Egitto 7
UZ - Uzbekistan 7
IL - Israele 6
IR - Iran 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
BE - Belgio 5
BG - Bulgaria 5
BO - Bolivia 5
CZ - Repubblica Ceca 5
NI - Nicaragua 5
UY - Uruguay 5
PT - Portogallo 4
AZ - Azerbaigian 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
LB - Libano 3
MY - Malesia 3
OM - Oman 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
AO - Angola 2
BS - Bahamas 2
CG - Congo 2
CM - Camerun 2
EE - Estonia 2
ET - Etiopia 2
GH - Ghana 2
HU - Ungheria 2
JM - Giamaica 2
KH - Cambogia 2
KZ - Kazakistan 2
LC - Santa Lucia 2
LY - Libia 2
RO - Romania 2
SC - Seychelles 2
SN - Senegal 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BJ - Benin 1
BZ - Belize 1
CY - Cipro 1
Totale 13.977
Salva come PNG Salva come JPEG
Città #
Singapore 1.232
San Jose 726
Ashburn 379
Moscow 372
Hong Kong 354
Ho Chi Minh City 348
Chandler 308
Beijing 303
Hefei 262
Hanoi 230
Santa Clara 189
Munich 141
Naples 138
Lauterbourg 121
Los Angeles 112
Millbury 90
The Dalles 78
Boardman 75
Helsinki 75
Tokyo 75
Amsterdam 72
Boston 68
Buffalo 61
Napoli 55
New York 54
Lawrence 49
São Paulo 48
Rome 47
Des Moines 44
Princeton 43
Seoul 42
Haiphong 40
Redondo Beach 39
Frankfurt am Main 38
Da Nang 37
Council Bluffs 34
Dallas 33
Nanjing 30
Orem 29
Turku 27
Dong Ket 26
Nuremberg 26
Toronto 25
Milan 24
Wilmington 24
Warsaw 23
Jacksonville 22
Rio de Janeiro 22
Seattle 22
Mexico City 21
Bangkok 19
Denver 19
Dublin 19
Montreal 19
Phoenix 19
Atlanta 18
Falkenstein 18
Shanghai 18
Biên Hòa 17
Chennai 17
Houston 17
Chicago 16
London 16
Marsala 16
Washington 16
Hebei 15
Stockholm 15
Brasília 14
Brooklyn 14
Changsha 14
Nanchang 14
Curitiba 13
Düsseldorf 13
Fairfield 13
Jiaxing 13
Krefeld 13
Ottawa 13
San Francisco 13
Guangzhou 12
Hải Dương 12
Johannesburg 11
Manchester 11
Poplar 11
Quận Bình Thạnh 11
Vienna 11
Woodbridge 11
Xi'an 11
Augusta 10
Baghdad 10
Bologna 10
Charlotte 10
Thái Bình 10
Buenos Aires 9
Can Tho 9
Dhaka 9
Genoa 9
Guayaquil 9
Lappeenranta 9
Mumbai 9
Nha Trang 9
Totale 7.397
Salva come PNG Salva come JPEG
Nome #
Short-term treatment of iron deficiency anemia after cardiac surgery 268
Efficacy, safety, adherence and persistence of PCSK9 inhibitors in clinical practice: A single country, multicenter, observational study (AT-TARGET-IT) 261
Dyslipidemia in Transplant Patients: Which Therapy? 208
Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study 159
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 155
A wide next-generation-sequencing panel improves the molecular diagnosis of dyslipidemias 151
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 150
Apo B, Small-dense LDL and carotid atherosclerosis in menopausal women 149
Atherogenic Lipoprotein Subfractions and Carotid Atherosclerosis in Menopausal Women 148
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 145
Association between small dense LDL and sub-clinical atherosclerosis in patients with psoriatic arthritis 145
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia: Systematic Review and Meta-Analysis of Randomized Controlled Trials 145
Association between small dense LDL and early atherosclerosis in a sample of menopausal women. 143
Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement 142
Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study 141
Association between small dense LDL particles and early atherosclerosis in a sample of middle-aged women. Findings from Progetto Atena 138
Effects of Bisphosphonate Treatment on Circulating Lipid and Glucose Levels in Patients with Metabolic Bone Disorders 137
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 137
Lipoprotein(A) where do we stand? from the physiopathology to innovative terapy 135
Efficacy and safety of lomitapide in familial chylomicronaemia syndrome 131
Predictive and prognostic markers in a cohort of Mediterranean women:review from Atena project 131
Inhibitors of Protein Convertase Subtilisin/Kexin 9 (PCSK9) and Acute Coronary Syndrome (ACS): The State-of-the-Art 131
Carotid Atherosclerosis, Ultrasound and Lipoproteins 130
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features. 130
Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia 129
New Ultrasound Technologies for Ischemic Heart Disease Assessment and Monitoring in Cardiac Rehabilitation 129
Association between Non-HDL-C/HDL-C Ratio and Carotid Intima-Media Thickness in Post-Menopausal Women. 129
Case Report: Genetic Analysis of PEG-Asparaginase Induced Severe Hypertriglyceridemia in an Adult With Acute Lymphoblastic Leukaemia 128
Association between Very Low-Density Lipoprotein Cholesterol (VLDL-C) and Carotid Intima-Media Thickness in Postmenopausal Women Without Overt Cardiovascular Disease and on LDL-C Target Levels. 127
Frailty in Acute and Chronic Coronary Syndrome Patients Entering Cardiac Rehabilitation 126
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 125
Effects of weight modification on hs-crp in a cohort of mediterranean women: findings from progetto atena. 125
Aterosclerosi preclinica 125
Screening for Familial Combined Hyperlipidemia criteria in a cohort of Mediterranean women: findings from Progetto ATENA 124
Renal involvement in COVID-19: focus on kidney transplant sector 124
A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia 123
Association of systemic lupus erythematosus with peripheral arterial disease: a meta-analysis of literature studies 123
Iodine Requirements in Pediatrics: From Fetal Life to Adolescence 122
Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: a pooled analysis of literature studies 122
Creatinine levels and intima media thickness in a population based cohort study: finding from Progetto Atena. 122
Impact of 12-SNP and 6-SNP Polygenic Scores on Predisposition to High LDL-Cholesterol Levels in Patients with Familial Hypercholesterolemia 121
More inflammation in Familial Hypercholesterolemia than in Familial Combined Hyperlipidemia. 121
Authors’ response to letter by Sbrana et al. “Evolocumab improve intima media thickness regression in He-FH subjects on lipoprotein apheresis” 121
Impaired endothelium-dependent vascular reactivity in patients with familial combined hyperlipidaemia. 120
Inflammatory markers in Familial Combined Hyperlipidemia 120
Association between Lp (a) and atherosclerosis in menopausal women without metabolic syndrome. 120
Changes in carotid stiffness in patients with familial hypercholesterolemia treated with Evolocumab®: A prospective cohort study 120
Association between body shape index and small dense LDL particles in a cohort of mediterranean women: Findings from Progetto ATENA 118
Exercise Training in Patients with Heart Failure: From Pathophysiology to Exercise Prescription 118
Sex-related differences in response to lomitapide in HoFH: A subanalysis of the Pan-European Lomitapide retrospective observational study 117
Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy 117
Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat? 117
Fat mass and vascular health in overweight/obese children 117
Venous thromboembolism and major bleeding in severe and critical COVID-19 hospitalized patients 116
A height-weight formula to measure body fat in childhood obesity 115
SMALL DENSE LDL IN RELATION TO CHANGES IN OXIDATION MARKERS AND VASCULAR REACTIVITYIN PATIENTS WITH HYPERCHOLESTEROLEMIA TREATED WITH EVOLOCUMAB: A PROSPECTIVE COHORT STUDY 115
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 115
Assessment of Platelet Aggregation and Thrombin Generation in Patients with Familial Chylomicronemia Syndrome Treated with Volanesorsen: A Cross-Sectional Study 114
Biochemical Screening for Familial Combined Hyperlipidemia 114
EVOLOCUMAB IS EFFECTIVE AND SAFE TO TREAT HYPERCHOLESTEROLEMIA IN A PATIENT WITH STATIN-INDUCED NECROTIZING MYOPATHY 113
Exercise Training in Elderly Cancer Patients: A Systematic Review 112
ipotiroidismo subclinico ed aterosclerosi carotidea 112
Idiopathic Osteoporosis and Nephrolithiasis: Two Sides of the Same Coin? 112
Association of apolipoprotein levels with peripheral arterial disease: a meta-analysis of literature studies 112
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 111
Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study 111
Familial Combined hyperlipidemia and IMT 111
Association between Lp(a) and small dense LDL in menopausal women without metabolic syndrome 111
Evinacumab for Homozygous Familial Hypercholesterolemia: The Italian Cohort of the ELIPSE HoFH Study 110
Association between small dense ldl and cardiovascular events in Familial combined hyperlipidemia. 110
Sacubitril/Valsartan Improves Autonomic Function and Cardiopulmonary Parameters in Patients with Heart Failure with Reduced Ejection Fraction 110
The bone-heart axis in the pathogenesis of cardiovascular diseases: A narrative review 109
Tumor Necrosis Factor-α is a marker of Familial Conbined Hyperlipidemia, independently of metabolic sindrome 109
Pathophysiological Role of Synovitis in Hemophilic Arthropathy Development: A Two-Hit Hypothesis 109
Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations 109
Early carotid atherosclerosis in obesity and overweight is independent of hs-CRP in a cohort of mediterranean women: findings from Progetto Atena 108
Tumor necrosis factor-α is a marker of familial combined hyperlipidemia, independently of metabolic syndrome 107
Clinical Evidence for Q10 Coenzyme Supplementation in Heart Failure: From Energetics to Functional Improvement 107
Società per lo studio dell'aterosclerosi ( Sezione Campania) 106
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey 105
[How to overcome barriers to implementation of prevention and management strategies of atherosclerotic cardiovascular disease through lipid-lowering therapy] 104
The relationship between BMI and common carotid plaques or Apo B and bifurcation plaques are independent of hs-CPR concentration: findings from Progetto ATENA 104
Relation of body mass index with carotid intima-media thickness and diameter is independent of metabolic syndrome in postmenopausal Mediterranean women. 103
Effects of short-term reduction in serum cholesterol with simvastatin in patients with stable angina pectoris and mild to moderate hypercholesterolemia 103
Lipoprotein (a) is an independent predictor of cardiovascular events in Mediterranean women (Progetto Atena) 103
Small dense low-density lipoprotein in familial combined hyperlipidemia: Independent of metabolic syndrome and related to history of cardiovascular events. 103
New insights into the management of homozygous familial hypercholesterolemia patients treated with lomitapide: a single-center experience 103
Oltre le statine quale terapia per l'ipercolesterolemia: gli inibitori del pCSK9 e l'inclisiran 102
High endogenous estradiol is associated with increased venous distensibility and clinical evidence of varicose veins in menopausal women. 100
Carotid artery wall hypertrophy in children with metabolic syndrome 100
Evinacumab for Homozygous Familial Hypercholesterolemia 100
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Use for Atherogenic Dyslipidemia in Solid Organ Transplant Patients 99
Relation of body mass index with intima media thickness and diameters is independent of metabolic syndrome in post menopausal women. 98
Aterosclerosi subclinica. influenza dei geni e dell' ambiente 98
Response to Letter to the Editor: "Association of Vitamin D Deficiency With Peripheral Arterial Disease: A Meta-Analysis of Literature Studies" 98
Exercise for slowing the progression of atherosclerotic process: effects on inflammatory markers 96
Oncology and Cardiac Rehabilitation: An Underrated Relationship 94
Efficacy and safety of lipid-lowering therapies in combination with or without statin to reduce the cardiovascular risk: A systematic review of randomised controlled trials 93
Diagnosis and Screening Strategies for Detection of Familial Hypercholesterolaemia in Children and Adolescents in Italy: A Survey from the LIPIGEN Paediatric Group 93
Comparison of two diets of varying glycemic index on carotid subclinical atherosclerosis in obese children. 91
Totale 12.238
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.939
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202174 0 0 0 0 0 0 0 0 0 0 40 34
2021/2022527 7 9 7 6 17 3 3 31 22 78 135 209
2022/2023807 97 57 37 46 96 85 5 81 113 71 93 26
2023/2024774 65 91 53 43 47 84 11 94 21 38 120 107
2024/20254.083 182 146 44 102 82 283 444 277 256 493 1.452 322
2025/20267.398 791 617 806 709 1.271 296 771 394 1.044 450 249 0
Totale 14.219